Intra-Cellular Therapies Inc. buy RudolfL
Start price
25.01.22
/
60%
€40.53
Target price
30.01.23
€65.00
Performance (%)
10.09%
End price
20.01.23
€44.62
Summary
This prediction ended on 20.01.23 with a price of €44.62. The prediction had a final performance of 10.09%. RudolfL has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - | - |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% | 60.023% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% | 85.321% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% | 61.038% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% | 57.738% |
Comments by RudolfL for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Buy mit Kursziel 48,0
Kursziel geändert auf 65,0
In the thread Trading Intra-Cellular Therapies Inc.
Buy beendet

